November 2024 – Page 4

Sarepta Therapeutics and Arrowhead Pharmaceuticals Enter $10 Billion Collaboration for Rare Disease Treatments

5 months ago talkbio0Tagged Arrowhead, biotech, Collaboration, Drug Industry, Genetic Medicine, Infrequent, RNA Interference

Sarepta Therapeutics, Arrowhead Pharmaceuticals, RNAi, Rare Diseases, Genetic Medicine, Collaboration Agreement, Biotech, Pharmaceutical Industry

Adcendo Secures $135M for ADC Pipeline Development

5 months ago talkbio0Tagged Adcendo, Cancer Therapeutic Procedure, Clinical Trials, pipeline, therapeutic autologous dendritic cells

Adcendo, ADC pipeline, funding, biotech, cancer treatment, clinical trials

Biohaven’s Taldefgrobep Alfa Shifts Focus to Obesity After Missing Primary Endpoint in Spinal Muscular Atrophy Phase 3 Trial

5 months ago talkbio0Tagged Alfa, Body Composition, Bone and Bones, density, GDF8 protein, human, Inhibitor, lean, Obesity, Phase 3 trial, Spinal Muscular Atrophy

Biohaven, taldefgrobep alfa, spinal muscular atrophy (SMA), obesity, myostatin inhibitor, phase 3 trial, body composition, lean muscle mass, bone density.

Gilead Sciences Acquires Investigational HIV Vaccine Assets from AELIX Therapeutics

5 months ago talkbio0Tagged Antigens, Gilead Sciences, HIV Vaccine, HIVACAT, HTI

Gilead Sciences, AELIX Therapeutics, HIV vaccine, HTI immunogen, IrsiCaixa, HIVACAT program

Merck’s Winrevair Demonstrates Significant Mortality Benefit in Pulmonary Arterial Hypertension Patients

5 months ago talkbio0Tagged Benefit, Co., Mortality Vital Statistics, PAH, Pulmonary arterial hypertension, Sotatercept, Winrevair

Winrevair, Pulmonary Arterial Hypertension (PAH), Mortality Benefit, Sotatercept, Merck & Co.

Cassava Sciences’ Alzheimer’s Drug Fails in Clinical Trial, Stock Plummets

5 months ago talkbio0Tagged Alzheimer 's disease, Clinical Trials, decline, Failure (biologic function), Manihot esculenta

Cassava Sciences, Alzheimer’s disease, clinical trial failure, ReThink-ALZ study, stock decline

Incyte Unveils Promising Monjuvi Data at ASH24, Paving Way for FDA Label Expansion in Follicular Lymphoma

5 months ago talkbio0Tagged ASH24, expansion, Incyte, Lymphoma, Follicular, Monjuvi, Phase 3 trial, United States Food and Drug Administration

Incyte, Monjuvi, ASH24, Follicular Lymphoma, Label Expansion, FDA, Phase 3 Trial

AstraZeneca’s Truqap Achieves Phase 3 Success in Prostate Cancer, Paving Way for Label Expansion

5 months ago talkbio0Tagged Antiandrogen therapy, AstraZeneca, CAPItello-281, Hormone Responsive, Malignant neoplasm of prostate, Metastatic to, Phase 3 trial, Progression-Free Survival, PTEN-deficient, Radiographic, rPFS, Truqap

AstraZeneca, Truqap, prostate cancer, Phase 3 trial, CAPItello-281, PTEN-deficient, metastatic hormone-sensitive prostate cancer, radiographic progression-free survival (rPFS), abiraterone, androgen deprivation therapy (ADT)